ATE333276T1 - Verwendung von thiolutin dioxide und ihren derivaten zur herstellung eines arzneimittels zur behandlung von zns-krankheiten - Google Patents
Verwendung von thiolutin dioxide und ihren derivaten zur herstellung eines arzneimittels zur behandlung von zns-krankheitenInfo
- Publication number
- ATE333276T1 ATE333276T1 AT02719902T AT02719902T ATE333276T1 AT E333276 T1 ATE333276 T1 AT E333276T1 AT 02719902 T AT02719902 T AT 02719902T AT 02719902 T AT02719902 T AT 02719902T AT E333276 T1 ATE333276 T1 AT E333276T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- treatment
- production
- medicinal product
- cns diseases
- Prior art date
Links
- MHMRAFONCSQAIA-UHFFFAOYSA-N thiolutin Chemical compound S1SC=C2N(C)C(=O)C(NC(=O)C)=C21 MHMRAFONCSQAIA-UHFFFAOYSA-N 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- LJRHSDGQWGPCCR-UHFFFAOYSA-N thiolutin Natural products S1SC=C2NC(=O)C(NC(=O)C)C21 LJRHSDGQWGPCCR-UHFFFAOYSA-N 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 244000005700 microbiome Species 0.000 abstract 2
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 abstract 1
- 230000004151 fermentation Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01105959A EP1238668A1 (de) | 2001-03-09 | 2001-03-09 | Verwendung von thiolutin dioxide und ihren derivaten zur herstellung eines arzneimittels zur behandlung von zns-krankheiten und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE333276T1 true ATE333276T1 (de) | 2006-08-15 |
Family
ID=8176735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02719902T ATE333276T1 (de) | 2001-03-09 | 2002-02-23 | Verwendung von thiolutin dioxide und ihren derivaten zur herstellung eines arzneimittels zur behandlung von zns-krankheiten |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US20020193418A1 (de) |
| EP (2) | EP1238668A1 (de) |
| JP (1) | JP2004521927A (de) |
| KR (1) | KR20040025902A (de) |
| CN (1) | CN1279906C (de) |
| AT (1) | ATE333276T1 (de) |
| AU (1) | AU2002250997B2 (de) |
| BG (1) | BG108161A (de) |
| BR (1) | BR0207884A (de) |
| CA (1) | CA2439853A1 (de) |
| CZ (1) | CZ20032427A3 (de) |
| DE (1) | DE60213219D1 (de) |
| EE (1) | EE200300430A (de) |
| HR (1) | HRP20030714A2 (de) |
| IL (1) | IL157792A0 (de) |
| MX (1) | MXPA03007551A (de) |
| NO (1) | NO20033964L (de) |
| NZ (1) | NZ528071A (de) |
| PL (1) | PL363374A1 (de) |
| RU (1) | RU2003129889A (de) |
| SK (1) | SK11202003A3 (de) |
| WO (1) | WO2002072089A2 (de) |
| YU (1) | YU68403A (de) |
| ZA (1) | ZA200306474B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108371661B (zh) * | 2018-01-19 | 2019-03-19 | 中国人民解放军军事科学院军事医学研究院 | 硫藤黄菌素在抑制nlrp3炎症小体活化中的应用 |
| CN113209088B (zh) * | 2021-03-11 | 2022-03-22 | 中国人民解放军军事科学院军事医学研究院 | 硫藤黄菌素在保护非酒精性脂肪性肝炎中的应用 |
| CN115261422B (zh) * | 2022-06-30 | 2024-07-16 | 塔里木大学 | 一种新物种来源硫藤黄菌素的制备方法及应用 |
| CN118477070B (zh) * | 2024-05-15 | 2025-09-09 | 中国人民解放军军事科学院军事医学研究院 | 硫藤黄菌素在预防和/或治疗放射性肺损伤中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU752376B2 (en) * | 1995-04-11 | 2002-09-19 | Welichem Biotech Inc. | Xenorxides with antibacterial and antimycotic properties |
| CA2212237A1 (en) * | 1997-09-05 | 1999-03-05 | John M. Webster | Novel antineoplastic agents |
-
2001
- 2001-03-09 EP EP01105959A patent/EP1238668A1/de not_active Withdrawn
-
2002
- 2002-02-23 DE DE60213219T patent/DE60213219D1/de not_active Expired - Lifetime
- 2002-02-23 KR KR10-2003-7011817A patent/KR20040025902A/ko not_active Withdrawn
- 2002-02-23 YU YU68403A patent/YU68403A/sh unknown
- 2002-02-23 PL PL02363374A patent/PL363374A1/xx unknown
- 2002-02-23 BR BR0207884-8A patent/BR0207884A/pt not_active IP Right Cessation
- 2002-02-23 AT AT02719902T patent/ATE333276T1/de not_active IP Right Cessation
- 2002-02-23 IL IL15779202A patent/IL157792A0/xx unknown
- 2002-02-23 RU RU2003129889/15A patent/RU2003129889A/ru not_active Application Discontinuation
- 2002-02-23 NZ NZ528071A patent/NZ528071A/en unknown
- 2002-02-23 CA CA002439853A patent/CA2439853A1/en not_active Abandoned
- 2002-02-23 HR HR20030714A patent/HRP20030714A2/xx not_active Application Discontinuation
- 2002-02-23 JP JP2002571048A patent/JP2004521927A/ja not_active Abandoned
- 2002-02-23 CZ CZ20032427A patent/CZ20032427A3/cs unknown
- 2002-02-23 WO PCT/EP2002/001915 patent/WO2002072089A2/en not_active Ceased
- 2002-02-23 CN CNB028079493A patent/CN1279906C/zh not_active Expired - Fee Related
- 2002-02-23 EE EEP200300430A patent/EE200300430A/xx unknown
- 2002-02-23 MX MXPA03007551A patent/MXPA03007551A/es unknown
- 2002-02-23 SK SK1120-2003A patent/SK11202003A3/sk unknown
- 2002-02-23 EP EP02719902A patent/EP1372640B1/de not_active Expired - Lifetime
- 2002-02-23 AU AU2002250997A patent/AU2002250997B2/en not_active Ceased
- 2002-03-08 US US10/092,882 patent/US20020193418A1/en not_active Abandoned
-
2003
- 2003-08-20 ZA ZA200306474A patent/ZA200306474B/en unknown
- 2003-09-08 BG BG108161A patent/BG108161A/xx unknown
- 2003-09-08 NO NO20033964A patent/NO20033964L/no unknown
-
2004
- 2004-10-26 US US10/973,309 patent/US20050059725A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03007551A (es) | 2003-12-04 |
| US20050059725A1 (en) | 2005-03-17 |
| KR20040025902A (ko) | 2004-03-26 |
| YU68403A (sh) | 2006-08-17 |
| CN1279906C (zh) | 2006-10-18 |
| PL363374A1 (en) | 2004-11-15 |
| AU2002250997B2 (en) | 2006-03-09 |
| WO2002072089A3 (en) | 2002-11-14 |
| EP1372640B1 (de) | 2006-07-19 |
| CN1501800A (zh) | 2004-06-02 |
| WO2002072089A2 (en) | 2002-09-19 |
| ZA200306474B (en) | 2004-04-29 |
| NO20033964D0 (no) | 2003-09-08 |
| SK11202003A3 (sk) | 2004-02-03 |
| RU2003129889A (ru) | 2005-03-10 |
| NO20033964L (no) | 2003-09-08 |
| CZ20032427A3 (cs) | 2004-01-14 |
| CA2439853A1 (en) | 2002-09-19 |
| DE60213219D1 (de) | 2006-08-31 |
| HRP20030714A2 (en) | 2005-04-30 |
| EP1372640A2 (de) | 2004-01-02 |
| US20020193418A1 (en) | 2002-12-19 |
| BR0207884A (pt) | 2004-07-27 |
| BG108161A (en) | 2004-09-30 |
| JP2004521927A (ja) | 2004-07-22 |
| EE200300430A (et) | 2003-12-15 |
| EP1238668A1 (de) | 2002-09-11 |
| NZ528071A (en) | 2005-02-25 |
| IL157792A0 (en) | 2004-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE427114T1 (de) | Verwendung von hepcidin zur herstellung eines arzneimittels zur behandlung von eisenhomíostase stírungen | |
| DE69428130D1 (de) | Verwendung von bcl-2 zur herstellung von arzneimitteln zur therapeutischen behandlung und verhinderung von krankheiten | |
| ATE342964T1 (de) | Rekombinante alpha-l-iduronisase, deren herstellungs- und aufreinigungsverfahren, und behandlung von durch diese hervorgerufene mangelerkrankungen | |
| NO20053263D0 (no) | Hydroksyetylaminderivater for behandling av Alzheimers sykdom. | |
| TW200420550A (en) | Thiazole compounds for the treatment of neurodegenerative disorders | |
| ATE293976T1 (de) | Verbindungen enthaltend s-tofisopam sowie verwendung dieser verbindungen zur herstellung eines medikamentes zur behandlung oder prophylaxe von krämpfen und anfällen | |
| DE60213219D1 (de) | Verwendung von thiolutin dioxide und ihren derivaten zur herstellung eines arzneimittels zur behandlung von zns-krankheiten | |
| ATE252383T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
| ATE334124T1 (de) | Chinolinderivate, herstellungsprozess und verwendung zur behandlung von krankheiten, bei den s-cd23 involviert ist | |
| ATE334680T1 (de) | 4-aminopiperidin-derivate, verfahren zur herstellung und ihre verwendung als arzneimittel | |
| DK1255734T3 (da) | Hidtil ukendte isatin-derivater | |
| DE68903907D1 (de) | Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen. | |
| DE60228988D1 (de) | Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen | |
| ATE492285T1 (de) | Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis | |
| ATE402150T1 (de) | Pyrazolaminverbindungen zur behandlung neurodegenerativer erkrankungen | |
| ATE186640T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung neurogenerativer erkrankungen | |
| ATE359995T1 (de) | Amin-1,2- und -1,3-diolverbindungen und deren verwendung zur behandlung von alzheimer-krankheit | |
| ATE192650T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
| BRPI0415529A (pt) | derivados de bengamida, processos para produção dos mesmos e uso dos mesmos para tratamento de doenças cancerosas | |
| DE69717961D1 (de) | Verwendung eines flavonoid enthaltenden extraktes der planze euphorbia prostrata zur herstellung eines medikamentes zur behandlung von anoraktalen oder kolonbeschwerden | |
| ATE173921T1 (de) | Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen | |
| ATE397597T1 (de) | Neue thiophenacylhydrazinoderivate, verfahren zu deren herstellung, deren verwendung als arzneimittel, pharmazeutische zusammensetzungen und neue anwendungen | |
| MXPA04001951A (es) | Coniosulfuros y sus derivados, procesos para prepararlos, y su uso como farmaceuticos. | |
| DE50102262D1 (de) | Verwendung von 2-methyl-thiazolidin 2,4-dicarbonsäure zur herstellung eines medikaments zur behandlung von infektionskrankheiten | |
| ATE300304T1 (de) | Verwendung von xanthinederivaten zur herstellung eines arzneimittels zur behandlung oder verhütung von osteoporose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |